BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20805139)

  • 1. Familial vitreous amyloidosis linked with factor V Leiden deficiency.
    Moortgat I; Van Ginderdeuren R; Van Calster J
    Br J Ophthalmol; 2011 Dec; 95(12):1755, 1762. PubMed ID: 20805139
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.
    Beirão NM; Matos E; Beirão I; Costa PP; Torres P
    Retina; 2011; 31(7):1373-7. PubMed ID: 21358362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy.
    Miyahara T; Ohta K; Yamamoto Y; Ueno A; Murata T
    J Glaucoma; 2007 Jan; 16(1):169-70. PubMed ID: 17224769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreal deposits in Val71Ala transthyretin amyloidosis.
    Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
    Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
    [No Abstract]   [Full Text] [Related]  

  • 5. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
    Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
    Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary vitreous amyloidosis. Apropos of a case with ultrastructural study].
    Goberville M; Korobelnik JF; D'Hermies F; Cotinat J; Savoldelli M; Chauvaud D; Pouliquen Y
    J Fr Ophtalmol; 1994; 17(6-7):418-22. PubMed ID: 8083492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy.
    Koga T; Ando E; Hirata A; Fukushima M; Kimura A; Ando Y; Negi A; Tanihara H
    Am J Ophthalmol; 2003 Feb; 135(2):188-93. PubMed ID: 12566023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up findings on aspiration cytology of amyloid from vitreous fluid.
    Gupta RK; Halliwell T; Naran S; Lallu S; Fauck R
    Diagn Cytopathol; 2004 Nov; 31(5):319-20. PubMed ID: 15468139
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of vitrectomy in suspected vitreous amyloidosis].
    Morice C; Dutheil C; Rougier MB; Delyfer MN; Korobelnik JF; Léger F
    J Fr Ophtalmol; 2019 Dec; 42(10):e463-e464. PubMed ID: 31253434
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular Manifestations of Familial Transthyretin Amyloidosis.
    Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
    Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual Vitreous Opacity in a Chinese Patient.
    Yu S; Xu Y; Liang X
    JAMA Ophthalmol; 2019 Dec; 137(12):1454-1455. PubMed ID: 31621813
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspiration cytodiagnosis of amyloid from vitreous fluid.
    Gupta RK; Wakefield J; Halliwell T; Foo K; Lallu S; Naran S; Fauck R
    Diagn Cytopathol; 2002 May; 26(5):294-6. PubMed ID: 11992370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
    Solano JM; Pulido JS; Salomao DR
    Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amyloidosis of the vitreous body. Possibilities of diagnosis].
    Soltau JB; Seiberth V; Knorz MC; Liesenhoff H
    Fortschr Ophthalmol; 1991; 88(4):408-10. PubMed ID: 1786932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
    Ishida K; Nishida T; Niimi Y; Suemori S; Mochizuki K; Kawakami H; Kimura A; Hirayama T
    Ophthalmic Genet; 2017; 38(4):387-391. PubMed ID: 28085522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous amyloidosis without systemic or familial involvement.
    Salvador F; Mateo C; Alegre J; Reventos A; García-Arumi J; Corcostegui B
    Int Ophthalmol; 1993-1994; 17(6):355-7. PubMed ID: 8063479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities.
    Monteiro JG; Martins AF; Figueira A; Saraiva MJ; Costa PP
    Eye (Lond); 1991; 5 ( Pt 1)():99-105. PubMed ID: 2060679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolated vitreous amyloidosis].
    Vermuso L; Gueudry J; Sauvêtre G; Piton N; Guerrot AM; Sturtz F; Portmann A; Muraine M
    J Fr Ophtalmol; 2017 Jan; 40(1):e7-e9. PubMed ID: 28065461
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical case of the month: non-familial vitreous amyloidosis].
    Tek A; Rakic JM
    Rev Med Liege; 2013; 68(7-8):396-8. PubMed ID: 24053097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous opacities in a case of familial amyloidotic polyneuropathy associated with a transthyretin Lys 54.
    Imasawa M; Toda Y; Sakurada Y; Imai M; Iijima H
    Acta Ophthalmol Scand; 2004 Oct; 82(5):635-7. PubMed ID: 15453875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.